Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell analysis of the cellular landscape of vulvar melanoma provides new insight for immunotherapy administration. | BMC Cancer | 2024 | 38233802 | PubTator, text mining | PubMed |
| Inhibition of Ephrin B2 Reverse Signaling Abolishes Multiple Myeloma Pathogenesis. | Cancer Res | 2024 | 38231476 | PubTator, text mining | PubMed |
| Trends in Acupuncture Therapy for Microcirculation and Hemorheology from 1998 to 2023: A Bibliometric and Visualized Study. | J Pain Res | 2024 | 38223661 | PubTator, text mining | PubMed |
| The intricate cellular ecosystem of human peripheral veins as revealed by single-cell transcriptomic analysis. | PLoS One | 2024 | 38206912 | PubTator, text mining | PubMed |
| Specific Circular RNA Signature of Endothelial Cells: Potential Implications in Vascular Pathophysiology. | Int J Mol Sci | 2024 | 38203852 | PubTator, text mining | PubMed |
| Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions. | Cancer Cell Int | 2024 | 38200584 | PubTator, text mining | PubMed |
| MET fusions are targetable genomic variants in the treatment of advanced malignancies. | Cell Commun Signal | 2024 | 38195556 | PubTator, text mining | PubMed |
| Transcriptomic signatures of individual cell types in cerebral cavernous malformation. | Cell Commun Signal | 2024 | 38195510 | PubTator, text mining | PubMed |
| ADAMTS13 regulates angiogenic markers via Ephrin/Eph signaling in human mesenchymal stem cells under serum-deprivation stress. | Sci Rep | 2024 | 38177376 | PubTator, text mining | PubMed |
| Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets. | Signal Transduct Target Ther | 2024 | 38172098 | PubTator, text mining | PubMed |
| SAM domain variants of EPHB4 associated with aberrant signaling are linked to lymphatic-related fetal hydrops and facial dysmorphology. | Clin Genet | 2024 | 38151336 | PubTator, text mining | PubMed |
| N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells. | Epigenetics | 2024 | 38145548 | PubTator, text mining | PubMed |
| Deciphering the emerging landscape of HOX genes in cardiovascular biology, atherosclerosis and beyond (Review). | Int J Mol Med | 2024 | 38131178 | PubTator, text mining | PubMed |
| Unilateral segmental presentation and a novel EPHB4 gene variant in capillary malformation-arteriovenous malformation type 2. | Pediatr Dermatol | 2024 | 38092051 | PubTator, text mining | PubMed |
| EGR1 modulates EPHB4-induced trophoblast dysfunction in recurrent spontaneous abortion†. | Biol Reprod | 2024 | 38091979 | PubTator, text mining | PubMed |
| Treatment for Gorham-Stout syndrome with a combination of teriparatide and denosumab. | Osteoporos Int | 2024 | 38062162 | PubTator, text mining | PubMed |
| Phosphoproteomics and morphology of stored human red blood cells treated by protein tyrosine phosphatases inhibitor. | Blood Adv | 2024 | 37910801 | PubTator, text mining | PubMed |
| Biological Significance of EphB4 Expression in Cancer. | Curr Protein Pept Sci | 2024 | 37909437 | PubTator, text mining | PubMed |
| Advances in cardiac tissue engineering and heart-on-a-chip. | J Biomed Mater Res A | 2024 | 37909362 | PubTator, text mining | PubMed |
| Crosstalk between glioblastoma and tumor microenvironment drives proneural-mesenchymal transition through ligand-receptor interactions. | Genes Dis | 2024 | 37692522 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=8